15
04 '21
Ninth Circuit Revives FCA Claim Based on “Fraud on the FDA”
The Ninth Circuit recently revived a claim in a qui tam lawsuit against a medical device manufacturer based on a “fraud on the FDA” theory of liability under the False […]